Who are Ethinyl Estradiol-cyprosterone acetate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Ethinyl Estradiol / Norgestimate Oral Tablet, OC - Drospirenone plus Ethynylestradiol, Estradiol+Drospirenone, Ethinyl estradiol / dienogest, OCR, Estradiol valerate / dienogest.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/ethinyl-estradiol-cyprosterone-acetate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Ethinyl Estradiol-cyprosterone acetate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ethinyl Estradiol-cyprosterone acetate (Ethinyl Estradiol-cyprosterone acetate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Oral contraceptive; combined estrogen-progestin. Area: Gynecology; Endocrinology.

marketed Oral contraceptive; combined estrogen-progestin Estrogen receptor; progesterone receptor; androgen receptor (antagonist) Gynecology; Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Ethinyl Estradiol-cyprosterone acetate (Ethinyl Estradiol-cyprosterone acetate) — S.C.B. Medical College and Hospital. Ethinyl estradiol-cyproterone acetate is an oral contraceptive that suppresses ovulation through combined estrogenic and progestagenic activity while providing anti-androgenic effects.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Ethinyl Estradiol-cyprosterone acetate TARGET	Ethinyl Estradiol-cyprosterone acetate	S.C.B. Medical College and Hospital	marketed	Oral contraceptive; combined estrogen-progestin	Estrogen receptor; progesterone receptor; androgen receptor (antagonist)
Ethinyl Estradiol / Norgestimate Oral Tablet	Ethinyl Estradiol / Norgestimate Oral Tablet	University of Colorado, Denver	marketed	Oral contraceptive (combined estrogen-progestin)	Estrogen receptor and progesterone receptor
OC - Drospirenone plus Ethynylestradiol	OC - Drospirenone plus Ethynylestradiol	Federico II University	marketed	Combined oral contraceptive	Estrogen receptor, progesterone receptor, mineralocorticoid receptor
Estradiol+Drospirenone	Estradiol+Drospirenone	Brigham and Women's Hospital	marketed	Combined oral contraceptive	Estrogen receptors (ER-α, ER-β) and progesterone receptors (PR); mineralocorticoid receptor antagonism
Ethinyl estradiol / dienogest	Ethinyl estradiol / dienogest	Helsinki University Central Hospital	marketed	Combined oral contraceptive	Estrogen receptor, progesterone receptor
OCR	OCR	Hoffmann-La Roche	marketed	Combined oral contraceptive	Estrogen receptor and progesterone receptor
Estradiol valerate / dienogest	Estradiol valerate / dienogest	Helsinki University Central Hospital	marketed	Oral contraceptive (combined estrogen-progestin)	Estrogen receptor and progesterone receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Oral contraceptive; combined estrogen-progestin class)

S.C.B. Medical College and Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Ethinyl Estradiol-cyprosterone acetate — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinyl-estradiol-cyprosterone-acetate. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab